|
Volumn 11, Issue 2, 2001, Pages 199-202
|
Myoclonus during prolonged treatment with sertraline in an adolescent patient
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETAZOLAMIDE;
AMITRIPTYLINE;
CITALOPRAM;
CLOMIPRAMINE;
CLONAZEPAM;
FLUOXETINE;
FLUVOXAMINE;
LOFEPRAMINE;
MAPROTILINE;
METHYLPHENIDATE;
MIANSERIN;
PAROXETINE;
SERTRALINE;
VALPROIC ACID;
ADOLESCENT;
ARTICLE;
CASE REPORT;
DEPRESSION;
DRUG INDUCED DISEASE;
DRUG WITHDRAWAL;
FEMALE;
HUMAN;
LONG TERM CARE;
MOTOR DYSFUNCTION;
MYOCLONUS;
RISK FACTOR;
TREATMENT OUTCOME;
ADOLESCENT;
ANTICONVULSANTS;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
CENTRAL NERVOUS SYSTEM STIMULANTS;
CHILD;
CHILD DEVELOPMENT DISORDERS, PERVASIVE;
CLONAZEPAM;
FEMALE;
HUMANS;
METHYLPHENIDATE;
MYOCLONUS;
PSEUDOTUMOR CEREBRI;
RISK FACTORS;
SERTRALINE;
|
EID: 0034949702
PISSN: 10445463
EISSN: None
Source Type: Journal
DOI: 10.1089/104454601750284126 Document Type: Article |
Times cited : (15)
|
References (14)
|